Roche to Create 1,000 Jobs in CN; Progenics, Salix Plummet on Relistor Rebuff - July 30, 2012

Having trouble viewing this email? View in Browser.

Monday, July 30, 2012  |   |   |   |  Increase the odds of identifying a functional biomarker pattern using our comprehensive protein biomarker services. Please click here for more information.   •  Roche (RHHBY) to Create 1,000 Jobs in CN More... •  Progenics Pharmaceuticals, Inc. (PGNX), Salix Pharmaceuticals, Ltd. (SLXP) Plummet on Relistor Rebuff More... •  Parkinson's Specialist Spins Out From Merck Serono's Soon-to-close R&D Ops More... •  Pfizer Inc. (PFE) Terminates License to 3 Products With Acura Pharmaceuticals, Inc. (ACUR)'s Technology More... •  Eli Lilly and Company (LLY)'s Solanezumab May Fail Pivotal Studies More... •  Gilead Sciences, Inc. (GILD)'s Single Pill Hepatitis C Study Targets 2014 Approval More... •  Novartis AG (NVS) Drug Afinitor Gets EU Nod for Breast Cancer More... •  Icahn Wins Legal Fight Over Forest Laboratories, Inc. (FRX) Books More... More Top News Fast and Simple RNA Sequencing by Invitrogen: The Ion PGM™ Sequencer puts RNA-Seq within reach of any lab, providing a fast, affordable, easy-to-use system for expression analysis of miRNA and mRNA. Offering better sensitivity, the Ion PGM™ Sequencer generates data superior to that obtained using microarrays-for a comparable price. Please click here for more information. •  Pfizer Inc. (PFE)'s Avoidable Alzheimer's Drug Failure More... •  Scientists Discover Possible Antibiotics Alternative, Monash University Study More... •  Curry Compound May Curb Diabetes Risk, University of Nakomnayok Study More... •  Elusive Gene That Causes a Form of Blindness From Birth Discovered, Loyola University Study More... •  Gene Discovery Set to Help With Mysterious Paralysis of Childhood, Duke University Medical Center Study More... •  Molecule Found That Inhibits Recovery From Stroke, University of California, Los Angeles (UCLA) Study More... •  Boys' Impulsiveness May Result in Better Math Ability, Say University of Missouri Researchers More... •  High-Carb Diet Tied to Breast Cancer Risk for Some, International Agency for Research on Cancer Study More...   More Featured News The DTCC Consortium: Supporting the Research Community by Creating and Phenotyping Knockout Mouse Mutants to Provide Functional Annotation for Protein-Coding Genes Funded by the NIH as part of the second phase of the Knockout Mouse Project (KOMP2), the DTCC Consortium is creating a repository of knockout mouse lines and phenotype data as part of an international effort to help researchers develop better models of human disease. To learn more, click here: www.criver.com/info/DTCC. • Genetown (Boston, Massachusetts) Dana Farber Cancer Institute Senior Research Scientist Responsible for leadership of multiple early stage drug discovery teams working to discover novel oncology therapies and delineate their clinical path and supporting biomarker packages. • Biotech Beach (San Diego, California) Dart NeuroScience LLC Manager Lab Technology, Structural Biology Will be responsible for laboratory organizational efficiency and effectiveness and for establishing and maintaining the protein expression, purification and analytical systems of the laboratory. • Pharm Country (Basking Ridge, New Jersey) Celgene Principal Statistician Actively provide statistical support to the Clinical R&D Department. Provide statistical input into the design of protocols including preparation of the biostatistical analysis section. Suggest optimal statistical designs that are acceptable by regulators. • BioCapital (Gaithersburg, Maryland) MedImmune, LLC Patient Access Associate Responsible for addressing complex reimbursement issues, developing access strategies based on hotline and Specialty Pharmacy Provider data and market research with internal and external stakeholders, providing education and information relating to the utilization of available resources to support appropriate patient access to MedImmune therapies, including monitoring patient cases that come through MedImmune's Access 360™ program. • Biotech Bay (Santa Clara, California) Affymetrix Senior Commodity Manager Primary responsibility is to be the resident expert for the organization and its customers in the assigned commodity categories. The Commodity Manager must be capable of embracing and using the Strategic Sourcing process and effect savings within the assigned commodity groups, which may include direct (production) or indirect procurement. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! 2012 Pharm Country Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Pharm Country Career Fair, Bridgewater, NJ September 13, 2012 • Biotech Beach Career Fair, San Diego, CA September 20, 2012 • Biotech Bay Career Fair, Burlingame, CA October 3, 2012 • BioCapital Career Fair, Bethesda, MD October 9, 2012 • BioMidwest Career Fair, Lincolnshire, IL October 22, 2012 • Bio NC Career Fair, Durham, NC October 25, 2012 • Genetown Career Fair, Cambridge, MA November 5, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services The Future of R&D Outsourcing • Understand different sponsor/CRO working models currently practiced. • Identify emerging and future trends in the outsourcing market. • Understand the benefits of innovative partnership arrangements between pharma and CRO. Click Here for More Information. Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! Amicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury, New Jersey 08512 U.S.A. Phone: 609-662-2000 Fax: 609-662-2807 Amicus Therapeutics, Inc. is a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases. The Company is developing novel, first-in-class, small molecules called pharmacological chaperones, to treat human genetic diseases, including lysosomal storage diseases. More Company Profiles FREE Subscription to Pharmaceutical & Medical Packaging News Pharmaceutical & Medical Packaging News is a comprehensive resource for medical and pharmaceutical manufacturing professionals who need focused, reliable, and timely information to make intelligent packaging decisions. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.